Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis

被引:27
|
作者
Soergel, Fritz [1 ,2 ]
Malin, Jakob J. [3 ,4 ,5 ]
Hagmann, Henning [4 ,6 ]
Kinzig, Martina [1 ]
Bilal, Muhammad [7 ,8 ]
Eichenauer, Dennis A. [9 ]
Scherf-Clavel, Oliver [1 ,10 ]
Simonis, Alexander [3 ,4 ]
El Tabei, Lobna [7 ,8 ]
Fuhr, Uwe [7 ,8 ]
Rybniker, Jan [3 ,4 ,5 ]
机构
[1] IBMP Inst Biomed & Pharmaceut Res, Paul Ehrlich Str 19, D-90562 Nurnberg, Germany
[2] Univ Duisburg Essen, West German Heart & Vasc Ctr, Inst Pharmacol, Essen, Germany
[3] Univ Cologne, Div Infect Dis, Dept Internal Med 1, Cologne, Germany
[4] Univ Cologne, Ctr Mol Med Cologne CMMC, Fac Med, Cologne, Germany
[5] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany
[6] Univ Hosp Cologne, Dept Internal Med 2, Cologne, Germany
[7] Univ Cologne, Fac Med, Cologne, Germany
[8] Univ Cologne, Univ Hosp Cologne, Ctr Pharmacol, Dept Pharmacol 1, Cologne, Germany
[9] Univ Cologne, Ctr Integrated Oncol Aachen Bonn Cologne Dusseldo, Dept Internal Med 1, Intens Care Program, Cologne, Germany
[10] Univ Wurzburg, Inst Pharm & Food Chem, Wurzburg, Germany
关键词
D O I
10.1093/jac/dkaa500
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:825 / 827
页数:4
相关论文
共 50 条
  • [31] The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease
    Brophy, DF
    Wazny, LD
    Gehr, TWB
    Comstock, TJ
    Venitz, J
    PHARMACOTHERAPY, 2001, 21 (02): : 169 - 174
  • [32] End-stage kidney disease and COVID-19: An incentive to consider other renal replacement therapies
    Hejazi, Sima Sadat
    Hosseini, Meimanat
    Ebadi, Abbas
    Majd, Hamid Alavi
    NURSING PRACTICE TODAY, 2021, 8 (03): : 170 - 172
  • [33] End-Stage renal disease and 30-day mortality for adults with and without COVID-19
    Harrison, Stephanie L.
    Buckley, Benjamin J. R.
    Fazio-Eynullayeva, Elnara
    Underhill, Paula
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 83 : 93 - 95
  • [34] Rash in a Patient With End-Stage Renal Disease
    McConnell, Adam
    Griffin, Sarah Noel
    Miller, Jan
    AMERICAN FAMILY PHYSICIAN, 2024, 110 (01) : 81 - 82
  • [35] Calciphylaxis in a patient with end-stage renal disease
    Kim, YJ
    Chung, BS
    Choi, KC
    JOURNAL OF DERMATOLOGY, 2001, 28 (05): : 272 - 275
  • [36] Pheochromocytoma in a patient with end-stage renal disease
    Godfrey, JA
    Rickman, OB
    Williams, AW
    Thompson, GB
    Young, WF
    MAYO CLINIC PROCEEDINGS, 2001, 76 (09) : 953 - 957
  • [37] Influenza and the patient with end-stage renal disease
    Brendan T. Bowman
    Mitchell H. Rosner
    Journal of Nephrology, 2018, 31 : 225 - 230
  • [38] Influenza and the patient with end-stage renal disease
    Bowman, Brendan T.
    Rosner, Mitchell H.
    JOURNAL OF NEPHROLOGY, 2018, 31 (02) : 225 - 230
  • [39] Hypokalemia in an End-Stage Renal Disease Patient
    Verma, Ashish
    Shahid, Muhammad Hassaan
    Youngblood, Laura
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (09): : E385 - E386
  • [40] EFFECT OF HAEMODILUTION ON THYROID FUNCTION BEFORE AND AFTER HAEMODIALYSIS IN PATIENT WITH END-STAGE RENAL DISEASE
    Sanai, Toru
    Okamura, Ken
    Ikeda, Yuji
    Miyazono, Motoaki
    Onoue, Tomorow
    Fukumitsu, Toma
    Shimamatsu, Kazumasa
    Kitazono, Takanari
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1873 - 1873